Cargando…
Management of borderline ovarian tumors: A tertiary referral center experience in Egypt
BACKGROUND: In this retrospective study, we discuss our experience as a large tertiary referral center in Egypt in the management and follow-up of borderline tumors PATIENTS AND METHODS: This is a retrospective cohort study where all patients diagnosed with a borderline ovarian tumor at Oncology Cen...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478369/ https://www.ncbi.nlm.nih.gov/pubmed/36117821 http://dx.doi.org/10.3389/fsurg.2022.962820 |
_version_ | 1784790555509653504 |
---|---|
author | Gaballa, Khaled Abdelkhalek, Mohamed Fathi, Adel Refky, Basel Belal, Khaled elaraby, Moustafa Zuhdy, Mohammad |
author_facet | Gaballa, Khaled Abdelkhalek, Mohamed Fathi, Adel Refky, Basel Belal, Khaled elaraby, Moustafa Zuhdy, Mohammad |
author_sort | Gaballa, Khaled |
collection | PubMed |
description | BACKGROUND: In this retrospective study, we discuss our experience as a large tertiary referral center in Egypt in the management and follow-up of borderline tumors PATIENTS AND METHODS: This is a retrospective cohort study where all patients diagnosed with a borderline ovarian tumor at Oncology Center Mansoura University from November 2014 to June 2020 were included. Demographics, preoperative, operative, postoperative, pathologic, and oncologic follow-up data were retrieved from a prospectively maintained electronic database. The included patients were followed until April 2022. RESULTS: We included 27 patients with borderline ovarian tumors. The mean age of the study patients was 47.67 ± 16.39 years. The median CA 125 was 33 (6–304 U/ml). Frozen section examination was utilized in 13 patients (48.14%), where a diagnosis of borderline ovarian tumors was revealed in 8 patients. Recurrence was reported in one patient with serous type after approximately 26 months. The most common pathological type in our cohort was the mucinous borderline type reported in 14 patients (51.9%), followed by the serous type reported in 11 patients (40.7%), and the seromucinous type in 1 patient only. Patients with mucinous borderline type were significantly younger (40.083 ± 18.47 vs. 53.73 ± 11.91 years, p = 0.028). Interestingly, Cancer Antigen 125 levels were significantly higher in mucinous than serous and seromucinous types [67(16–304) vs. 20(6–294.6) U/ml, p = 0.027]. On the other hand, the radiological tumor size of serous and seromucinous types was larger than that of the mucinous type [23(19–31) cm vs. 8(5–20) cm, p = 0.001]. Over a median follow-up period of 58.66 (54.16–63.16) months, only one postoperative mortality was reported, while only one recurrence was reported. CONCLUSION: Borderline ovarian tumors still represent a dilemma either in diagnosis or management. A frozen section examination could help to reach a preliminary diagnosis. Total abdominal hysterectomy and bilateral salpingo-oophorectomy are the cornerstone of surgical management; however, fertility-sparing surgery could be a valid option for women desiring fertility. |
format | Online Article Text |
id | pubmed-9478369 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94783692022-09-17 Management of borderline ovarian tumors: A tertiary referral center experience in Egypt Gaballa, Khaled Abdelkhalek, Mohamed Fathi, Adel Refky, Basel Belal, Khaled elaraby, Moustafa Zuhdy, Mohammad Front Surg Surgery BACKGROUND: In this retrospective study, we discuss our experience as a large tertiary referral center in Egypt in the management and follow-up of borderline tumors PATIENTS AND METHODS: This is a retrospective cohort study where all patients diagnosed with a borderline ovarian tumor at Oncology Center Mansoura University from November 2014 to June 2020 were included. Demographics, preoperative, operative, postoperative, pathologic, and oncologic follow-up data were retrieved from a prospectively maintained electronic database. The included patients were followed until April 2022. RESULTS: We included 27 patients with borderline ovarian tumors. The mean age of the study patients was 47.67 ± 16.39 years. The median CA 125 was 33 (6–304 U/ml). Frozen section examination was utilized in 13 patients (48.14%), where a diagnosis of borderline ovarian tumors was revealed in 8 patients. Recurrence was reported in one patient with serous type after approximately 26 months. The most common pathological type in our cohort was the mucinous borderline type reported in 14 patients (51.9%), followed by the serous type reported in 11 patients (40.7%), and the seromucinous type in 1 patient only. Patients with mucinous borderline type were significantly younger (40.083 ± 18.47 vs. 53.73 ± 11.91 years, p = 0.028). Interestingly, Cancer Antigen 125 levels were significantly higher in mucinous than serous and seromucinous types [67(16–304) vs. 20(6–294.6) U/ml, p = 0.027]. On the other hand, the radiological tumor size of serous and seromucinous types was larger than that of the mucinous type [23(19–31) cm vs. 8(5–20) cm, p = 0.001]. Over a median follow-up period of 58.66 (54.16–63.16) months, only one postoperative mortality was reported, while only one recurrence was reported. CONCLUSION: Borderline ovarian tumors still represent a dilemma either in diagnosis or management. A frozen section examination could help to reach a preliminary diagnosis. Total abdominal hysterectomy and bilateral salpingo-oophorectomy are the cornerstone of surgical management; however, fertility-sparing surgery could be a valid option for women desiring fertility. Frontiers Media S.A. 2022-09-02 /pmc/articles/PMC9478369/ /pubmed/36117821 http://dx.doi.org/10.3389/fsurg.2022.962820 Text en © 2022 Gaballa, Abdelkhalek, Fathi, Refky, Belal, elaraby and Zuhdy. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Surgery Gaballa, Khaled Abdelkhalek, Mohamed Fathi, Adel Refky, Basel Belal, Khaled elaraby, Moustafa Zuhdy, Mohammad Management of borderline ovarian tumors: A tertiary referral center experience in Egypt |
title | Management of borderline ovarian tumors: A tertiary referral center experience in Egypt |
title_full | Management of borderline ovarian tumors: A tertiary referral center experience in Egypt |
title_fullStr | Management of borderline ovarian tumors: A tertiary referral center experience in Egypt |
title_full_unstemmed | Management of borderline ovarian tumors: A tertiary referral center experience in Egypt |
title_short | Management of borderline ovarian tumors: A tertiary referral center experience in Egypt |
title_sort | management of borderline ovarian tumors: a tertiary referral center experience in egypt |
topic | Surgery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478369/ https://www.ncbi.nlm.nih.gov/pubmed/36117821 http://dx.doi.org/10.3389/fsurg.2022.962820 |
work_keys_str_mv | AT gaballakhaled managementofborderlineovariantumorsatertiaryreferralcenterexperienceinegypt AT abdelkhalekmohamed managementofborderlineovariantumorsatertiaryreferralcenterexperienceinegypt AT fathiadel managementofborderlineovariantumorsatertiaryreferralcenterexperienceinegypt AT refkybasel managementofborderlineovariantumorsatertiaryreferralcenterexperienceinegypt AT belalkhaled managementofborderlineovariantumorsatertiaryreferralcenterexperienceinegypt AT elarabymoustafa managementofborderlineovariantumorsatertiaryreferralcenterexperienceinegypt AT zuhdymohammad managementofborderlineovariantumorsatertiaryreferralcenterexperienceinegypt |